Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
Washington University School of Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Brigham and Women's Hospital
University of Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Northwestern University
Case Comprehensive Cancer Center
University of Chicago
Fox Chase Cancer Center
Columbia University
OHSU Knight Cancer Institute
Herlev Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Wisconsin, Madison
University of Washington
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
University of Louisville
Washington University School of Medicine
Yale University
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
University of Massachusetts, Worcester
Indiana University
Indiana University
University of Chicago
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Northwestern University
NYU Langone Health